Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System

Gabriel Quesada,1 Daniel H Chang,2 Kevin L Waltz,3 Andrew A Kao,2 Rodrigo Quesada,1 Ying Wang,4 Leilei Ji,4 Dari Parizadeh,4 Luis Atiles4 1Grupo Oftalmo & Plastico, San Salvador, El Salvador; 2Empire Eye and Laser Center, Bakersfield, CA, USA; 3Central American Ophthalmic Research Consultants, I...

Full description

Bibliographic Details
Main Authors: Quesada G, Chang DH, Waltz KL, Kao AA, Quesada R, Wang Y, Ji L, Parizadeh D, Atiles L
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/clinical-performance-and-surgeon-acceptability-of-a-new-dual-mode-phac-peer-reviewed-fulltext-article-OPTH
_version_ 1828325022332092416
author Quesada G
Chang DH
Waltz KL
Kao AA
Quesada R
Wang Y
Ji L
Parizadeh D
Atiles L
author_facet Quesada G
Chang DH
Waltz KL
Kao AA
Quesada R
Wang Y
Ji L
Parizadeh D
Atiles L
author_sort Quesada G
collection DOAJ
description Gabriel Quesada,1 Daniel H Chang,2 Kevin L Waltz,3 Andrew A Kao,2 Rodrigo Quesada,1 Ying Wang,4 Leilei Ji,4 Dari Parizadeh,4 Luis Atiles4 1Grupo Oftalmo & Plastico, San Salvador, El Salvador; 2Empire Eye and Laser Center, Bakersfield, CA, USA; 3Central American Ophthalmic Research Consultants, Indianapolis, IN, USA; 4Johnson & Johnson Surgical Vision, Inc, Santa Ana, CA, USACorrespondence: Gabriel Quesada, Grupo Oftalmo & Plastico, 9 C Pte, 4625, Col Escalon, San Salvador, El Salvador, Tel +1 (503) 22579003, Email gabriel.quesadalarez@gmail.comPurpose: The purpose of this first in-human study was to evaluate the overall clinical performance of the VERITAS™ Vision System in patients scheduled to undergo cataract extraction and to confirm overall surgeon acceptability.Patients and methods: This prospective, open-label multinational study included adults with cataracts scheduled for planned cataract extraction and posterior chamber IOL implantation. Standard small-incision phacoemulsification cataract surgery with the VERITAS Vision System was conducted. Surgeons completed a questionnaire regarding their clinical experience with the VERITAS Vision System for each patient following surgery and 1-day postoperative. Corneal clarity and adverse events (AEs) were assessed. Surgeon acceptability was scored on a 5-point scale, with acceptability considered favorable for scores of 4 and 5.Results: A total of 115 eyes (79 patients) were treated. The El Salvador site treated 41 patients (58 eyes), and the US site treated 38 patients (57 eyes). Overall, surgeons were satisfied with the clinical performance regardless of the cataract grade. The satisfaction with anterior chamber stability, post-occlusion surge, followability, holdability, cutting efficiency, usability, and overall satisfaction with the VERITAS Vision System was clinically favorable in ≥ 99% of cases. Overall satisfaction with the swivel handpiece, foot pedal, and enhanced ergonomics were clinically favorable in ≥ 97% of cases regardless of the cataract grade. Satisfaction with corneal clarity at same-day postoperative and 1-day postoperative, and 1-day overall clinical results of surgery with the VERITAS Vision System were clinically favorable in ≥ 94% of cases regardless of cataract grade.Conclusion: The new dual-mode phacoemulsification system with dual-durometer tubing, gas forced infusion, new swivel handpiece, and ergonomics improvements resulted in a high rate of user satisfaction with clinical performance and ergonomics. The VERITAS Vision System is safe and effective when used as indicated.Keywords: VERITAS Vision System, cataract, ergonomics, fluidics, satisfaction
first_indexed 2024-04-13T19:16:02Z
format Article
id doaj.art-c64e0e2532ed456d90366027536afa3a
institution Directory Open Access Journal
issn 1177-5483
language English
last_indexed 2024-04-13T19:16:02Z
publishDate 2022-08-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj.art-c64e0e2532ed456d90366027536afa3a2022-12-22T02:33:41ZengDove Medical PressClinical Ophthalmology1177-54832022-08-01Volume 162441245177160Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification SystemQuesada GChang DHWaltz KLKao AAQuesada RWang YJi LParizadeh DAtiles LGabriel Quesada,1 Daniel H Chang,2 Kevin L Waltz,3 Andrew A Kao,2 Rodrigo Quesada,1 Ying Wang,4 Leilei Ji,4 Dari Parizadeh,4 Luis Atiles4 1Grupo Oftalmo & Plastico, San Salvador, El Salvador; 2Empire Eye and Laser Center, Bakersfield, CA, USA; 3Central American Ophthalmic Research Consultants, Indianapolis, IN, USA; 4Johnson & Johnson Surgical Vision, Inc, Santa Ana, CA, USACorrespondence: Gabriel Quesada, Grupo Oftalmo & Plastico, 9 C Pte, 4625, Col Escalon, San Salvador, El Salvador, Tel +1 (503) 22579003, Email gabriel.quesadalarez@gmail.comPurpose: The purpose of this first in-human study was to evaluate the overall clinical performance of the VERITAS™ Vision System in patients scheduled to undergo cataract extraction and to confirm overall surgeon acceptability.Patients and methods: This prospective, open-label multinational study included adults with cataracts scheduled for planned cataract extraction and posterior chamber IOL implantation. Standard small-incision phacoemulsification cataract surgery with the VERITAS Vision System was conducted. Surgeons completed a questionnaire regarding their clinical experience with the VERITAS Vision System for each patient following surgery and 1-day postoperative. Corneal clarity and adverse events (AEs) were assessed. Surgeon acceptability was scored on a 5-point scale, with acceptability considered favorable for scores of 4 and 5.Results: A total of 115 eyes (79 patients) were treated. The El Salvador site treated 41 patients (58 eyes), and the US site treated 38 patients (57 eyes). Overall, surgeons were satisfied with the clinical performance regardless of the cataract grade. The satisfaction with anterior chamber stability, post-occlusion surge, followability, holdability, cutting efficiency, usability, and overall satisfaction with the VERITAS Vision System was clinically favorable in ≥ 99% of cases. Overall satisfaction with the swivel handpiece, foot pedal, and enhanced ergonomics were clinically favorable in ≥ 97% of cases regardless of the cataract grade. Satisfaction with corneal clarity at same-day postoperative and 1-day postoperative, and 1-day overall clinical results of surgery with the VERITAS Vision System were clinically favorable in ≥ 94% of cases regardless of cataract grade.Conclusion: The new dual-mode phacoemulsification system with dual-durometer tubing, gas forced infusion, new swivel handpiece, and ergonomics improvements resulted in a high rate of user satisfaction with clinical performance and ergonomics. The VERITAS Vision System is safe and effective when used as indicated.Keywords: VERITAS Vision System, cataract, ergonomics, fluidics, satisfactionhttps://www.dovepress.com/clinical-performance-and-surgeon-acceptability-of-a-new-dual-mode-phac-peer-reviewed-fulltext-article-OPTHveritas vision systemcataractergonomicsfluidicssatisfaction
spellingShingle Quesada G
Chang DH
Waltz KL
Kao AA
Quesada R
Wang Y
Ji L
Parizadeh D
Atiles L
Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System
Clinical Ophthalmology
veritas vision system
cataract
ergonomics
fluidics
satisfaction
title Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System
title_full Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System
title_fullStr Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System
title_full_unstemmed Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System
title_short Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System
title_sort clinical performance and surgeon acceptability of a new dual mode phacoemulsification system
topic veritas vision system
cataract
ergonomics
fluidics
satisfaction
url https://www.dovepress.com/clinical-performance-and-surgeon-acceptability-of-a-new-dual-mode-phac-peer-reviewed-fulltext-article-OPTH
work_keys_str_mv AT quesadag clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT changdh clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT waltzkl clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT kaoaa clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT quesadar clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT wangy clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT jil clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT parizadehd clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem
AT atilesl clinicalperformanceandsurgeonacceptabilityofanewdualmodephacoemulsificationsystem